Krystal Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5011471027
USD
281.53
145.45 (106.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
97.80
96.04
88.18
91.14
83.84
70.28
45.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
97.80
96.04
88.18
91.14
83.84
70.28
45.25
Raw Material Cost
5.66
8.71
6.66
6.54
8.17
8.00
4.03
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
37.58
33.62
31.09
29.70
27.23
25.64
24.45
Other Expenses
1.32
1.44
1.43
1.35
1.35
1.56
1.10
Total Expenditure (Excl Depreciation)
56.43
56.73
52.01
49.76
48.91
49.22
39.43
Operating Profit (PBDIT) excl Other Income
41.4
39.300000000000004
36.2
41.4
34.900000000000006
21.099999999999998
5.8
Other Income
6.59
7.47
7.42
7.23
7.34
7.48
7.62
Operating Profit (PBDIT)
49.58
48.32
45.23
50.20
43.76
30.53
15.04
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
-12.50
-12.50
-12.50
Gross Profit (PBDT)
92.14
87.33
81.52
84.60
75.67
62.29
41.22
Depreciation
1.61
1.54
1.63
1.59
1.49
1.99
1.61
Profit Before Tax
47.97
46.77
43.60
48.61
29.77
16.05
0.93
Tax
-31.40
8.44
7.86
3.13
2.59
0.48
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
79.36
38.33
35.73
45.48
27.18
15.57
0.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
79.36
38.33
35.73
45.48
27.18
15.57
0.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
79.36
38.33
35.73
45.48
27.18
15.57
0.93
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,137.88
1,040.65
984.67
946.38
885.85
838.89
799.24
Earnings per share (EPS)
2.66
1.29
1.2
1.52
0.91
0.53
0.03
Diluted Earnings per share
2.66
1.29
1.2
1.52
0.91
0.53
0.03
Operating Profit Margin (Excl OI)
42.3%
40.93%
41.02%
45.4%
41.67%
29.97%
12.85%
Gross Profit Margin
50.69%
50.31%
51.29%
55.08%
37.28%
25.65%
5.62%
PAT Margin
81.15%
39.91%
40.52%
49.9%
32.42%
22.15%
2.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 16.71% vs 874.42% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 191.91% vs -66.29% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 18.13% vs 246.77% in Sep 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Krystal Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
97.80
170.99
-73.19
-42.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
97.80
170.99
-73.19
-42.80%
Raw Material Cost
5.66
14.32
-8.66
-60.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
3.38
-3.38
-100.00%
Selling and Distribution Expenses
37.58
149.55
-111.97
-74.87%
Other Expenses
1.32
3.67
-2.35
-64.03%
Total Expenditure (Excl Depreciation)
56.43
203.92
-147.49
-72.33%
Operating Profit (PBDIT) excl Other Income
41.37
-32.92
74.29
225.67%
Other Income
6.59
2.25
4.34
192.89%
Operating Profit (PBDIT)
49.58
-28.26
77.84
275.44%
Interest
0.00
3.38
-3.38
-100.00%
Exceptional Items
0.00
-13.19
13.19
100.00%
Gross Profit (PBDT)
92.14
156.67
-64.53
-41.19%
Depreciation
1.61
2.41
-0.80
-33.20%
Profit Before Tax
47.97
-47.23
95.20
201.57%
Tax
-31.40
0.00
-31.40
Provisions and contingencies
0
0
0.00
Profit After Tax
79.36
-47.23
126.59
268.03%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
79.36
-47.23
126.59
268.03%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
79.36
-47.23
126.59
268.03%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,137.88
73.73
1,064.15
1,443.31%
Earnings per share (EPS)
2.66
-0.94
3.60
382.98%
Diluted Earnings per share
2.66
-0.94
3.60
382.98%
Operating Profit Margin (Excl OI)
42.30%
-19.25%
0.00
61.55%
Gross Profit Margin
50.69%
-26.21%
0.00
76.90%
PAT Margin
81.15%
-27.62%
0.00
108.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 9.78 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 1.87% vs 8.84% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 16.71% vs 874.42% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 7.94 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 107.31% vs 7.28% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 191.91% vs -66.29% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.30 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.13% vs 8.20% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 18.13% vs 246.77% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 42.30%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024